ZBH
ZIMMER BIOMET HOLDINGS, INC.
-1.91 (-1.97%)94.88USD591K成交股數18.1B市值23.0本益比(近四季)2.1股價營收比+4.8%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.2B+14% | 2.1B+3% | 2.0B+10% | 2.1B+7% | 1.9B+1% | 2.0B+15% | 1.8B-2% | 1.9B+6% | 1.9B | 1.8B | 1.9B | 1.8B |
| 營業成本 | 636M | 576M | 559M | 592M | 550M | 587M | 539M | 554M | 512M | 519M | 526M | 501M |
| 毛利 | 1.5B+13% | 1.5B+5% | 1.4B+12% | 1.5B+7% | 1.4B-1% | 1.4B+16% | 1.3B-4% | 1.4B+4% | 1.4B | 1.2B | 1.3B | 1.3B |
| 毛利率 | 70.8% | 72.4% | 72.1% | 71.5% | 71.2% | 71.0% | 70.5% | 71.5% | 72.9% | 70.4% | 71.9% | 72.6% |
| 研發費用 | 105M | 103M | 116M | 113M | 111M | 109M | 112M | 109M | 108M | 117M | 118M | 110M |
| 銷售管理費用 | 899M | 850M | 811M | 815M | 759M | 747M | 710M | 737M | 736M | 675M | 726M | 716M |
| 營業利益 | 326M+12% | 373M-4% | 351M+26% | 300M-15% | 292M+10% | 389M+46% | 280M-15% | 351M+7% | 266M | 267M | 330M | 327M |
| 營業利益率 | 15.0% | 17.9% | 17.6% | 14.4% | 15.3% | 19.2% | 15.3% | 18.1% | 14.1% | 15.2% | 17.6% | 17.9% |
| 稅後淨利 | 198M+9% | 238M-1% | 231M-7% | 153M-37% | 182M+6% | 240M+47% | 249M+19% | 243M+4% | 172M | 163M | 210M | 233M |
| 淨利率 | 9.1% | 11.4% | 11.5% | 7.4% | 9.5% | 11.8% | 13.7% | 12.5% | 9.1% | 9.3% | 11.2% | 12.7% |
| 稀釋 EPS | 1.03+13% | 1.22+3% | 1.16-6% | 0.77-35% | 0.91+8% | 1.18+53% | 1.23+23% | 1.18+6% | 0.84 | 0.77 | 1.00 | 1.11 |
| 稀釋股數 | 193M | 196M | 199M | 198M | 200M | 204M | 203M | 206M | 206M | 210M | 210M | 210M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 410M | 424M | 1.3B | 557M | 1.4B | 526M | 569M | 420M | 393M | 292M | 320M | 330M |
| 應收帳款 | 1.8B | 1.7B | 1.6B | 1.6B | 1.5B | 1.5B | 1.5B | 1.4B | 1.4B | 1.3B | 1.4B | 1.4B |
| 存貨 | 2.3B | 2.2B | 2.5B | 2.5B | 2.2B | 2.2B | 2.4B | 2.4B | 2.4B | 2.3B | 2.3B | 2.2B |
| 總資產 | 22.8B | 22.7B | 23.5B | 22.9B | 22.2B | 21.4B | 21.7B | 21.5B | 21.5B | 21.2B | 21.3B | 21.2B |
| 有息負債 | 6.3B | 6.3B | 7.5B | 6.8B | 6.6B | 5.3B | 4.7B | 4.0B | 4.8B | 5.1B | 5.2B | 5.2B |
| 總負債 | 10.2B | 10.0B | 10.7B | 10.3B | 9.8B | 8.9B | 9.3B | 8.8B | 8.8B | 8.7B | 8.9B | 9.1B |
| 股東權益 | 12.6B | 12.7B | 12.8B | 12.5B | 12.4B | 12.5B | 12.4B | 12.7B | 12.6B | 12.5B | 12.4B | 12.2B |
| 負債比 | 44.6% | 44.2% | 45.6% | 45.2% | 44.1% | 41.6% | 43.0% | 40.8% | 41.2% | 41.0% | 41.9% | 42.8% |
| 淨現金(現金 − 有息負債) | −5.9B | −5.9B | −6.2B | −6.2B | −5.2B | −4.8B | −4.2B | −3.5B | −4.4B | −4.8B | −4.9B | −4.9B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 359M | – | – | 383M+68% | – | – | – | 228M | – | – | 308M |
| 資本支出 | – | 36.3M | – | – | 44.6M | – | – | – | 55.1M | – | – | 46.7M |
| 自由現金流 | – | 323M | – | – | 338M+96% | – | – | – | 173M | – | – | 261M |
| 折舊攤銷 | 271M | 270M | 284M | 272M | 254M | 264M | 251M | 243M | 239M | – | – | 232M |
| 買回庫藏股 | – | 250M | – | – | 230M | – | – | – | 114M | – | – | 268M |
| 現金股利 | – | 46.9M | – | – | 47.8M | – | – | – | 49.4M | – | – | 50.3M |
| 自由現金流率 | – | 15.5% | – | – | 17.7% | – | – | – | 9.2% | – | – | 14.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 6.5B
| 美國以外 | 3.5B | 53.3% | +7.0% |
|---|---|---|---|
| 歐洲中東非洲 | 1.8B | 27.6% | +6.7% |
| 亞太 | 1.2B | 19.1% | +4.5% |
| 美洲 小計 | 5.2B | 79.8% | +8.0% |
| 美國 小計 | 4.8B | 73.2% | +7.3% |
產品／服務2025 年度 · 8.2B
| Knees | 3.3B | 40.4% | +4.7% |
|---|---|---|---|
| SET | 2.2B | 26.1% | +15.2% |
| Hips | 2.1B | 25.4% | +4.7% |
| Technology And Data Bone Cement And Surgical | 666M | 8.1% | +4.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 8.2B | +7.2% | 705M | 8.6% | 3.55 | 1.5B |
| FY2024 | 7.7B | +3.8% | 904M | 11.8% | 4.43 | 1.3B |
| FY2023 | 7.4B | +6.5% | 1.0B | 13.8% | 4.88 | 1.3B |
| FY2022 | 6.9B | +1.6% | 231M | 3.3% | 1.10 | 1.2B |
| FY2021 | 6.8B | +11.4% | 402M | 5.9% | 1.91 | 1.4B |
| FY2020 | 6.1B | -12.0% | −139M | -2.3% | -0.67 | 1.1B |
| FY2019 | 7.0B | -12.3% | 1.1B | 16.3% | 5.47 | 1.4B |
| FY2018 | 7.9B | – | −379M | -4.8% | -1.86 | 1.6B |